Cargando…
Association of Low-Dose Quetiapine and Diabetes
IMPORTANCE: Quetiapine has been associated with increased risk of type 2 diabetes when used in medium or high doses for the treatment of severe mental disorders. It is not known whether low doses, commonly used off-label for sedative-hypnotic purposes, are also associated with increased risk of type...
Autores principales: | Højlund, Mikkel, Lund, Lars C., Andersen, Kjeld, Correll, Christoph U., Hallas, Jesper |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105749/ https://www.ncbi.nlm.nih.gov/pubmed/33961038 http://dx.doi.org/10.1001/jamanetworkopen.2021.3209 |
Ejemplares similares
-
Impact of low‐dose quetiapine‐use on glycosylated hemoglobin, triglyceride and cholesterol levels
por: Højlund, Mikkel, et al.
Publicado: (2022) -
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study
por: Højlund, Mikkel, et al.
Publicado: (2022) -
Use of antipsychotics in Denmark 1997–2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses
por: Højlund, M., et al.
Publicado: (2021) -
Who prescribes quetiapine in Denmark?
por: Højlund, Mikkel, et al.
Publicado: (2022) -
Free‐of‐charge dispensing of antipsychotics for schizophrenia in Denmark: Impact on the nationwide prescription registry and redemption of somatic medications
por: Rohde, Christopher, et al.
Publicado: (2022)